TNF and pulmonary fibrosis: In consistence with the current results, the administration of uMSCs reduced inflammation and inhibited the expression of transforming growth factor-β, and the proinflammatory cytokines (IL- 1 and 6), collagen I, macrophage migratory inhibitory factor, and TNF in bleomycin induced lung fibrosis in mice [21].